📄 Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.

Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.

keywords 🔗 Angiotensin receptor blockers (1) 🔗 Angiotensin-converting enzyme inhibitors (3) 🔗 COVID-19 (1240) 🔗 Renal and cardiac side effects () 🔗 SARS-CoV-2 (551) 🔗 Severe acute respiratory syndrome coronavirus (73)

download 🔖 [BibTeX]